Axon (AXON) CEO sells 10,000 shares under Rule 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Axon Enterprise CEO Patrick W. Smith reported an open-market sale of 10,000 shares of common stock at a weighted average price of $500.0018 per share on the reported transaction date. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 12, 2025.
Following this transaction, Smith directly holds 3,050,997 shares of Axon Enterprise common stock. The sale was carried out in multiple trades within a price range of $500.00 to $500.18, with the reported price reflecting the weighted average.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 10,000 shares ($5,000,018)
Net Sell
1 txn
Insider
SMITH PATRICK W
Role
CHIEF EXECUTIVE OFFICER
Sold
10,000 shs ($5.00M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 10,000 | $500.0018 | $5.00M |
Holdings After Transaction:
Common Stock — 3,050,997 shares (Direct, null)
Footnotes (1)
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025. The transaction was executed in multiple trades at prices ranging from $500.00 to $500.18. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Shares sold: 10,000 shares
Weighted average sale price: $500.0018 per share
Post-transaction holdings: 3,050,997 shares
+2 more
5 metrics
Shares sold
10,000 shares
Open-market sale of common stock
Weighted average sale price
$500.0018 per share
Sale of 10,000 shares
Post-transaction holdings
3,050,997 shares
Shares directly held after sale
Trade price range
$500.00 to $500.18
Multiple executions within the sale
10b5-1 plan adoption date
May 12, 2025
Date CEO adopted trading plan
Key Terms
Rule 10b5-1 trading plan, open-market sale, weighted average sales price, Form 4
4 terms
Rule 10b5-1 trading plan regulatory
"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
weighted average sales price financial
"The price reported above reflects the weighted average sales price."
Form 4 regulatory
"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan..."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What insider transaction did Axon (AXON) report for CEO Patrick W. Smith?
Axon reported that CEO Patrick W. Smith sold 10,000 shares of common stock in an open-market transaction. The sale was executed at a weighted average price of $500.0018 per share and was conducted under a pre-arranged Rule 10b5-1 trading plan.
Was the Axon (AXON) CEO’s stock sale made under a Rule 10b5-1 plan?
Yes. The filing states the transactions were effected under a Rule 10b5-1 trading plan adopted by Patrick W. Smith on May 12, 2025. Such plans allow pre-scheduled trades, which can make the timing less indicative of the insider’s short-term views.
What type of insider transaction did the Axon (AXON) Form 4 disclose?
The Form 4 disclosed a non-derivative open-market sale of common stock by the CEO. The transaction code was “S,” indicating a sale in the open market or a private transaction, and covered 10,000 shares at a weighted average sale price of $500.0018.